PEQLX | RMEBX | PEQLX / RMEBX | |
Total Expense Ratio | 0.64 | 1.07 | 60% |
Annual Report Gross Expense Ratio | 0.64 | 1.07 | 60% |
Fund Existence | 13 years | 11 years | - |
Gain YTD | 4.584 | 5.923 | 77% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 38B | 106B | 36% |
Annual Yield % from dividends | 1.32 | 1.16 | 114% |
Returns for 1 year | 4.36 | 8.54 | 51% |
Returns for 3 years | 34.09 | 27.89 | 122% |
Returns for 5 years | 67.03 | 58.69 | 114% |
Returns for 10 years | 87.79 | 68.22 | 129% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
ISHG | 75.17 | -0.28 | -0.37% |
iShares 1-3 Year International TrsBd ETF | |||
PICB | 23.83 | -0.12 | -0.50% |
Invesco International Corporate Bond ETF | |||
FMED | 23.74 | -0.18 | -0.75% |
Fidelity Disruptive Medicine ETF | |||
IYK | 70.76 | -0.66 | -0.92% |
iShares US Consumer Staples ETF | |||
IWM | 208.89 | -3.89 | -1.83% |
iShares Russell 2000 ETF |